These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7035762)

  • 1. Plasma half disappearance time and metabolic clearance rate of exogenous LH-RH in patients with chronic renal failure.
    Gryczyńska M; Kosowicz J; Czekalski S
    Mater Med Pol; 1980; 12(1-2):124-8. PubMed ID: 7035762
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.
    Pimstone B; Epstein S; Hamilton SM; LeRoith D; Hendricks S
    J Clin Endocrinol Metab; 1977 Feb; 44(2):356-60. PubMed ID: 320223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic clearance of recombinant human growth hormone in health and chronic renal failure.
    Haffner D; Schaefer F; Girard J; Ritz E; Mehls O
    J Clin Invest; 1994 Mar; 93(3):1163-71. PubMed ID: 8132756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic aspects of digoxin in patients with terminal renal failure. I. Off dialysis.
    van der Vijgh WJ
    Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):249-54. PubMed ID: 881276
    [No Abstract]   [Full Text] [Related]  

  • 5. Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
    Drinovec J; Mrhar A; Bren A; Primozic S; Karba R; Varl J; Kozjek F
    J Chemother; 1989 Jul; 1(4 Suppl):565-6. PubMed ID: 16312534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antibacterial chemotherapy in renal failure].
    Briedigkeit H
    Z Urol Nephrol; 1983 May; 76(5):349-52. PubMed ID: 6880421
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in blood thiamphenicol levels in renal failure.
    Traeger J; Moskovchenko J; Monier JC; Zech P
    Postgrad Med J; 1974 Oct; 50 Suppl 5():39-40. PubMed ID: 4470816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of propranolol and clonidine in patients during chronic intermittent hemodialysis treatment].
    Seiler KU; Hunecke R; Meyer GJ
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1612-4. PubMed ID: 611890
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic clearance and plasma half-disappearance time of exogenous somatostatin in man.
    Sheppard M; Shapiro B; Pimstone B; Kronheim S; Berelowitz M; Gregory M
    J Clin Endocrinol Metab; 1979 Jan; 48(1):50-3. PubMed ID: 422706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of recombinant hirudin in hemodialyzed end-stage renal failure patients.
    Vanholder R; Camez A; Veys N; Van Loo A; Dhondt AM; Ringoir S
    Thromb Haemost; 1997 Apr; 77(4):650-5. PubMed ID: 9134637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic clearance and plasma half-disappearance time of D-TRP6 and exogenous luteinizing hormone-releasing hormone.
    Barron JL; Millar RP; Searle D
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1169-73. PubMed ID: 6210706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate of disappearance in plasma of synthetic LH-RH intravenously injected in man.
    Fauconnier JP; Teuwissen B; Thomas K
    Gynecol Obstet Invest; 1978; 9(5):229-37. PubMed ID: 378777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma elimination of cardiac troponin I in end-stage renal disease.
    Ellis K; Dreisbach AW; Lertora JL
    South Med J; 2001 Oct; 94(10):993-6. PubMed ID: 11702827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Parenteral administration of a new cephalosporin in patients with chronic kidney failure. Study of plasmatic half-life of the antibiotic in relation to glomerular clearance].
    Malandain H; Humbert G; Fillastre JP; Acar J; Dubois D; Leroy J; Robert M; Daufresne MF
    Pathol Biol (Paris); 1973 Mar; 21(3):233-9. PubMed ID: 4574486
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetic behavior of clofibrate in patients with kidney insufficiency].
    Hartlapp J; Kürten J; Klehr U; Gugler R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1709-11. PubMed ID: 611915
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of amoxycillin and ampicillin in patients with renal failure.
    Ksiazek A; Twardowski Z; Przyborowski L; Majdan M; Sokołowska G; Hopkała H; Solski J; Zbikowska A; Misztal G; Bocheńska-Nowacka E
    Ann Univ Mariae Curie Sklodowska Med; 1983; 38():79-86. PubMed ID: 6600085
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics of nicotine in kidney failure.
    Molander L; Hansson A; Lunell E; Alainentalo L; Hoffmann M; Larsson R
    Clin Pharmacol Ther; 2000 Sep; 68(3):250-60. PubMed ID: 11014406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kidney function in hypertensive patients with chronic renal failure treated with the dual eliminated ACE-inhibitor spirapril].
    Haufe CC; Sierakowski B; Jansa U; Stein G
    Med Klin (Munich); 1994 Aug; 89(8):416-20. PubMed ID: 7968874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship between plasma cephalothin clearance and endogenous creatinine clearance. V].
    Sieniawska M; Wróblewska-Kałuzewska M; Białasik D; Karczeńska J; Wierzba K
    Pediatr Pol; 1980 Jun; 55(6):699-705. PubMed ID: 7413318
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.